Short- versus long-course therapy in gram-negative bacilli bloodstream infections

[1]  S. Ambretti,et al.  Treatment duration for Escherichia coli bloodstream infection and outcomes: retrospective single-centre study. , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  E. Bouza,et al.  Executive summary: Diagnosis and Treatment of Catheter-Related Bloodstream Infection: Clinical Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) and the Spanish Society of Intensive Care Medicine and Coronary Units (SEMICYUC). , 2018, Enfermedades infecciosas y microbiologia clinica.

[3]  S. Cosgrove,et al.  Comparing the Outcomes of Adults With Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score–Matched Cohort , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  H. Albrecht,et al.  Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections , 2017, Infection.

[5]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[6]  A. Del Arco,et al.  Predictors of early mortality in very elderly patients with bacteremia: a prospective multicenter cohort. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[7]  G. Rossi,et al.  Relapsing bloodstream infections during treatment of acute leukemia , 2014, Annals of Hematology.

[8]  S. Cosgrove,et al.  Short versus prolonged courses of antibiotic therapy for children with uncomplicated Gram-negative bacteraemia. , 2014, The Journal of antimicrobial chemotherapy.

[9]  M. Al-Hasan,et al.  Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[10]  C. Clancy,et al.  Epidemiology, Clinical Characteristics and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Infections among Solid Organ Transplant Recipients , 2012, PloS one.

[11]  R. Fowler,et al.  Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis , 2011, Critical care.

[12]  D. Warren,et al.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  E. Bouza,et al.  Recurrent Escherichia coli Bloodstream Infections: Epidemiology and Risk Factors , 2009, Medicine.

[14]  J. Rhee,et al.  SCORING SYSTEMS FOR PREDICTION OF MORTALITY IN PATIENTS WITH INTENSIVE CARE UNIT-ACQUIRED SEPSIS: A COMPARISON OF THE PITT BACTEREMIA SCORE AND THE ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION II SCORING SYSTEMS , 2009, Shock.

[15]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[16]  S. Janković,et al.  Nosocomial bloodstream infections in ICU and non-ICU patients. , 2005, American journal of infection control.

[17]  M. Singer,et al.  Variability of treatment duration for bacteraemia in the critically ill: a multinational survey. , 2003, The Journal of antimicrobial chemotherapy.

[18]  Daniel J Sexton,et al.  Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections , 2002, Annals of Internal Medicine.

[19]  R. Arbeit,et al.  Recurrent Escherichia coli bacteremia , 1994, Journal of clinical microbiology.

[20]  H. Albrecht,et al.  Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis , 2017 .

[21]  R. Fowler,et al.  Duration of antibiotic therapy for critically ill patients with bloodstream infections: A retrospective cohort study. , 2013, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[22]  K. Riesenberg,et al.  Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia. , 2001, Scandinavian journal of infectious diseases.

[23]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.